Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Loma Negra Shares Plunge Following Disastrous Quarterly Report

Robert Sasse by Robert Sasse
August 29, 2025
in Stocks
0
Loma Negra Compania Industrial Argentina Sociedad Anonima Stock
0
SHARES
349
VIEWS
Share on FacebookShare on Twitter

Investor confidence in Argentine cement producer Loma Negra Compania Industrial Argentina Sociedad Anonima evaporated after the company released shockingly poor second-quarter 2025 results. A toxic combination of collapsing profitability and missed expectations triggered a severe market reaction, raising questions about the underlying causes and whether any positive elements exist within the dismal report.

Financial Metrics Signal Deep Trouble

The quarterly figures present a sobering picture for shareholders. Loma Negra’s net income experienced a catastrophic decline, plummeting to just 385 million pesos. This figure represents a tiny fraction of the prior year’s result, which exceeded 41 billion pesos. The earnings per share performance proved even more startling, with actual results of $0.0005 per share missing analyst expectations of $0.1555 by a staggering 99.68 percent.

Revenue performance also deteriorated significantly. Net sales registered an 8 percent year-over-year decrease, primarily driven by substantial weakness in the core cement business. Compounding these issues, the company’s adjusted EBITDA margin contracted sharply from 29.2 percent to 21.2 percent.

Mixed Operational Performance Amid Market Pressure

Despite the financial turmoil, Loma Negra reported increased sales volumes within its cement division. Cement deliveries actually advanced by 11.1 percent, fueled by ongoing industrial and commercial projects alongside major housing initiatives. However, this volume growth proved insufficient to counterbalance intense price competition within the market, resulting in noticeably lower revenue per ton.

Should investors sell immediately? Or is it worth buying Loma Negra Compania Industrial Argentina Sociedad Anonima?

One segment provided a glimmer of positivity. The railway division reported substantially improved performance, with its EBITDA margin expanding by 351 basis points to reach 9.8 percent. This enhancement was supported by increased transport volumes and the company’s disciplined approach to cost management.

Deteriorating Financial Position and Bearish Sentiment

The company’s financial health showed clear signs of strain. Net debt to EBITDA ratio worsened considerably, climbing from 0.89x to 1.34x. On a more positive note, Loma Negra addressed near-term obligations through a $112.9 million bond issuance in July, using the proceeds to service maturing debt and strengthen its liquidity position.

Market sentiment has turned decisively negative. Technical analysis indicates persistent selling signals, and the equity has shed a quarter of its value since reaching a peak on August 6. Particularly concerning for bulls, short interest in Loma Negra shares surged by 95.81 percent recently, indicating many market participants anticipate further price depreciation.

Even after the severe decline, the company’s valuation remains ambitious with a price-to-earnings ratio of 31. The critical question for investors is whether current challenges represent temporary headwinds or indicate more profound, structural problems facing the business.

Ad

Loma Negra Compania Industrial Argentina Sociedad Anonima Stock: Buy or Sell?! New Loma Negra Compania Industrial Argentina Sociedad Anonima Analysis from February 7 delivers the answer:

The latest Loma Negra Compania Industrial Argentina Sociedad Anonima figures speak for themselves: Urgent action needed for Loma Negra Compania Industrial Argentina Sociedad Anonima investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Loma Negra Compania Industrial Argentina Sociedad Anonima: Buy or sell? Read more here...

Tags: Loma Negra Compania Industrial Argentina Sociedad Anonima
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Banco Macro Stock

Despite Record Profit Surge, Banco Macro Shares Tumble on Guidance Concerns

SkillsoftClass A Common Stock Stock

Skillsoft Shares Face Critical Test Amid Steep Decline

Reservoir Media Stock

Reservoir Media's Strategic Expansion Meets Financial Headwinds

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com